NCT02317705 - Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Ovarian Cancer

Interventions

DRUG

OTL38

DEVICE

Near infrared camera imaging system

PROCEDURE

Laparotomy

primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery

Trial Locations (4)

University of Pennsylvania, Philadelphia

Moffitt Cancer Center, Tampa

Mayo Clinic-Rochester, Rochester

University of CA at Irvine Chao Cancer Center, Orange